UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000060676
Receipt number R000069399
Scientific Title Effects of dynamic stretching on mechanical properties of lower limb muscles and athletic performance: A quantitative investigation using ultrasound imaging
Date of disclosure of the study information 2026/02/14
Last modified on 2026/02/14 15:43:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of dynamic stretching on leg muscle flexibility and exercise performance: A study using ultrasound

Acronym

Changes in muscle flexibility and performance after stretching

Scientific Title

Effects of dynamic stretching on mechanical properties of lower limb muscles and athletic performance: A quantitative investigation using ultrasound imaging

Scientific Title:Acronym

Lower limb dynamic stretching: Muscle mechanical properties and performance - Quantitative ultrasound study

Region

Japan


Condition

Condition

None

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Through this research, we aim to propose optimal intervention conditions for enhancing flexibility and provide foundational evidence that contributes to the establishment of effective stretching protocols and the prevention of sports injuries.The objective of this study is to quantitatively evaluate the effects of dynamic stretching (DS) on the mechanical properties of lower limb muscles and to clarify whether the reduction in muscle-tendon unit (MTU) stiffness is attributable to changes in the mechanical properties of individual muscles. Furthermore, the study investigates the dose-response relationship regarding the effects of DS on muscle mechanical properties, muscle performance, and jump performance.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Measurement Timing is Pre- and post-intervention (each session), and during inter-set intervals of the dynamic stretching protocol.
Outcome Measures is Shear modulus, Peak joint angle, Passive torque, Isometric muscle strength, Isokinetic muscle strength

Key secondary outcomes

Measurement Timing is Pre- and post-intervention (each session), and during inter-set intervals of the dynamic stretching protocol.
Outcome Measures is Countermovement jump (CMJ), Squat jump (SJ)


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Dose comparison

Stratification

YES

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

Central registration


Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Maneuver

Interventions/Control_1

1 set of forward leg swings (dynamic stretching) involving hip flexion and extension in the sagittal plane.

Interventions/Control_2

3 set of forward leg swings (dynamic stretching) involving hip flexion and extension in the sagittal plane.

Interventions/Control_3

5 set of forward leg swings (dynamic stretching) involving hip flexion and extension in the sagittal plane.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

29 years-old >=

Gender

Male and Female

Key inclusion criteria

The subjects are healthy young adults with no motor dysfunction in the trunk or lower limbs, consisting of individuals classified by range of motion (ROM) measurements into two groups: those with normal flexibility and those with decreased lower limb flexibility.

Key exclusion criteria

Individuals with a history of orthopedic injury or surgery involving the trunk or lower limbs within the past six months, as well as those currently presenting with neuromuscular or cardiac diseases, are excluded from the study.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Keigo
Middle name
Last name Taniguchi

Organization

Sapporo Medical University

Division name

Department of Physical Therapy, School of Health Sciences

Zip code

060-8556

Address

School of Health Sciences, Sapporo Medical University, South-1, West-17, Chuo-Ku, Sapporo, Hokkaido, Japan

TEL

011-611-2111

Email

ktani@sapmed.ac.jp


Public contact

Name of contact person

1st name Shota
Middle name
Last name Hirayama

Organization

Sapporo Medical University Graduate School

Division name

Division of Biological Function Evaluation, Department of Physical Therapy and Occupational Therapy

Zip code

060-8556

Address

School of Health Sciences, Sapporo Medical University, South-1, West-17, Chuo-Ku, Sapporo, Hokkaido

TEL

011-611-2111

Homepage URL


Email

h.s82spt@gmail.com


Sponsor or person

Institute

Sapporo Medical University Graduate School

Institute

Department

Personal name

Hirayama Shota


Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sapporo Medical University Graduate School

Address

School of Health Sciences, Sapporo Medical University, South-1, West-17, Chuo-Ku, Sapporo, Hokkaido

Tel

011-611-2111

Email

h.s82spt@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 02 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2026 Year 04 Month 30 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 02 Month 14 Day

Last modified on

2026 Year 02 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069399